Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe

Abstract 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a new psychoactive substance with strong hallucinogenic properties. Our previous data reported increased release of dopamine, serotonin, and glutamate after acute injections and a tolerance development in the neurotransmi...

Full description

Bibliographic Details
Main Authors:	Monika Herian, Adam Wojtas, Marzena Maćkowiak, Agnieszka Wawrzczak-Bargiela, Anna Solarz, Agnieszka Bysiek, Katarzyna Madej, Krystyna Gołembiowska
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-02-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-07069-8

Similar Items

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study
by: Adam Wojtas, et al.
Published: (2023-12-01)

Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
by: Adam Wojtas, et al.
Published: (2022-06-01)

Chronic psychosis associated with new hallucinogenic drug 25I-NBOMe
by: O. Martin-Santiago, et al.
Published: (2023-03-01)

Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures
by: Larissa Marcely Gomes Cassiano, et al.
Published: (2023-07-01)

Epigenetic Targets in Schizophrenia Development and Therapy
by: Agnieszka Wawrzczak-Bargieła, et al.
Published: (2023-03-01)

25C-NBOMe Ingestion
by: Jonathan Zygowiec, et al.
Published: (2017-10-01)

Environmental neurotoxicology /
by: National Research Council (Unites States). Committee on Neurotoxicology and Models for Assessing Risk
Published: (1992)

Rewarding and Reinforcing Effects of 25H-NBOMe in Rodents
by: Cheolmin Jo, et al.
Published: (2022-11-01)

Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia
by: Wiktor Bilecki, et al.
Published: (2021-08-01)

Molecular and Medical Aspects of Psychedelics
by: Adam Wojtas, et al.
Published: (2023-12-01)

NBOMes–Highly Potent and Toxic Alternatives of LSD
by: Jolanta B. Zawilska, et al.
Published: (2020-02-01)

Editorial: Women in neurotoxicology: 2021
by: Monica Renee Langley, et al.
Published: (2023-09-01)

Editorial: Methods and protocols in neurotoxicology
by: Ellen Fritsche, et al.
Published: (2022-10-01)

Neurotoxicological Effects of Environmental and Occupational Agents
by: Rabia Gökçen Gözübatik Çelik, et al.
Published: (2022-06-01)

Editorial: Rising stars in neurotoxicology: 2021
by: Katharina Koch, et al.
Published: (2023-03-01)

Current State of Developmental Neurotoxicology Research
by: David R Wallace
Published: (2015-10-01)

The Future of Neurotoxicology: A Neuroelectrophysiological Viewpoint
by: David W. Herr
Published: (2021-12-01)

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
by: Cristina Miliano, et al.
Published: (2019-12-01)

Is Shame Hallucinogenic?
by: Simon McCarthy-Jones
Published: (2017-08-01)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
by: Grant Jones, et al.
Published: (2023-12-01)

The Potential Role of Serotonergic Hallucinogens in Depression Treatment
by: Dominika Psiuk, et al.
Published: (2021-07-01)

Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs
by: Micaela Tirri, et al.
Published: (2022-04-01)

Neurotoxicology of alcohol: a bibliometric and science mapping analysis
by: Paulo Fernando Santos Mendes, et al.
Published: (2023-08-01)

NBOMe: a new dangerous drug similar to LSD
by: Lysa Remy, et al.
Published: (2015-12-01)

Zebrafish and Artemia salina in vivo evaluation of the recreational 25C-NBOMe drug demonstrates its high toxicity
by: Natalie Álvarez-Alarcón, et al.
Published: (2021-01-01)

Drosophila melanogaster as a Model for Lead Neurotoxicology and Toxicogenomics Research
by: Douglas Mark Ruden, et al.
Published: (2012-05-01)

New Psychoactive Substances Constant State of Flux: NBOMe Brazilian Case
by: Carlos Alberto Yasin Wayhs, et al.
Published: (2021-11-01)

Hallucinogens : a forensic drug handbook /
by: Laing, Richard R., et al.
Published: (2003)

Effects of hallucinogenic drugs on the human heart
by: Joachim Neumann, et al.
Published: (2024-02-01)

Psychedelic medicine and the clinical application of hallucinogens
by: eClinicalMedicine
Published: (2023-02-01)

Editorial: Neuropharmacological and neurotoxicological advances using in vivo non-mammalian model organisms
by: Lijie Xia, et al.
Published: (2023-09-01)

Automatic identification of NBOMe illicit psychoactive substances based on combined molecular descriptors
by: Ion Adelina, et al.
Published: (2021-01-01)

Dimethyltryptamine: hallucinogenic alkaloid on the Central Nervous System
by: Darliane Freire Almeida, et al.
Published: (2018-01-01)

Hallucinogenic drugs in pre-Columbian Mesoamerican cultures
by: F.J. Carod-Artal
Published: (2015-01-01)

2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG
by: Pâmella F. dos Santos, et al.
Published: (2016-02-01)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
by: Rafael G. dos Santos, et al.

25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and <i>C. elegans—</i>Structure Determination and Synthesis of the Most Abundant Metabolites
by: Anna Šuláková, et al.
Published: (2021-03-01)

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms
by: P. Chue, et al.
Published: (2022-06-01)

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
by: Vern Lewis, et al.
Published: (2023-03-01)

High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research
by: Hubbard Kyle S, et al.
Published: (2012-10-01)